Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

151

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

LSD analogue with potential for treating schizophrenia

Related Posts

Pseudomonas infections persisting after CFTR modulators are widespread throughoutthe lungs and drive lung inflammation

Pseudomonas infections persisting after CFTR modulators...

99

A microprotein atlas of the human frontal cortex in Alzheimer’s disease

A microprotein atlas of the human frontal cortex in Alz...

46

The subiculum: cell-type-specific composition, computation, and function

The subiculum: cell-type-specific composition, computat...

94